Frontier Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
RI
Frontier Capital Management's RARE Position: Q2 2026 in Review
Frontier Capital Management increased its Ultragenyx Pharmaceutical (RARE) stake by 30% in Q2 2026, buying an estimated $16.3M and bringing the position to 2,847,936 shares worth $95.1M. The position accounts for 0.89% of the portfolio, ranked #19.
Frontier Capital Management first reported a position in RARE in Q2 2025 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.
- Frontier Capital Management held 2,847,936 shares of Ultragenyx Pharmaceutical worth $95.1M as of Q2 2026.
- Frontier Capital Management bought 656,754 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $16.3M.
- Ultragenyx Pharmaceutical made up 0.89% of Frontier Capital Management's portfolio in Q2 2026, its #19 holding.
- Frontier Capital Management first reported a position in Ultragenyx Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
- 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.
Based on Frontier Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.